From: Decreased response inhibition in middle-aged male patients with type 2 diabetes
 | OW patients | NW patients | OW controls | NW controls | DM* | OW* | Interaction* |
---|---|---|---|---|---|---|---|
<Go/NoGo task> | Â | Â | Â | Â | Â | Â | Â |
Discriminability (d') | 2.66 ± 0.48 | 2.39 ± 1.0 | 3.14 ± 0.59 | 3.28 ± 0.46 | 0.001‡ | 0.648 | 0.215 |
   Commission errors | 9.8 ± 3.8 | 10.1 ± 3.8 | 6.6 ± 4.2 | 5.5 ± 2.9 | 0.002‡ | 0.74 | 0.463 |
   Omission errors | 0.4 ± 0.9 | 3.8 ± 8.0 | 0.2 ± 0.4 | 0.1 ± 0.3 | 0.049†| 0.081 | 0.072 |
RT (ms) | 356 ± 28 | 330 ± 59 | 339 ± 37 | 363 ± 35 | 0.104 | 0.629 | 0.009†|
Post-error slowing (ms) | 379 ± 66 | 322 ± 68 | 348 ± 57 | 343 ± 40 | 0.525 | 0.035†| 0.054 |
<Reversal and extinction tasks> | |||||||
Errors after reversal | 1.7 ± 3.0 | 1.2 ± 0.4 | 1.1 ± 0.3 | 1.0 ± 0.4 | 0.977 | 0.358 | 0.448 |
Errors after extinction | 7.6 ± 3.7 | 6.4 ± 4.0 | 8.7 ± 5.2 | 5.1 ± 3.0 | 0.894 | 0.029†| 0.340 |
<WCST> | Â | Â | Â | Â | Â | Â | Â |
Achievement scores | 5.4 ± 1.0 | 4.6 ± 1.3 | 5.9 ± 0.6 | 5.6 ± 0.5 | 0.218 | 0.117 | 0.773 |
% perseverative errors | 2.7 ± 6.4 | 8.2 ± 10.1 | 4.2 ± 9.0 | 3.2 ± 5.3 | 0.458 | 0.296 | 0.147 |